Revital (Tali) Hirsch

medical devices medtech healthcare data analytics medtech innovation innovation business model venture capital fda pma approval process regulatory mdufa decision class iii medical devices mdufa us regulatory system pma class 3 medical devices generic pma ce mark us-eu device lag start-ups payment models fee for service value based care economies of scale disruptors milken institute medical technology march 2013 time magazine bitter pill steven brill